Education
About Us
Working with TipRanks
Follow Us
CryoPort Inc (CYRX)
NASDAQ:CYRX
CYRX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$4.58 - $20.11
Previous CloseN/A
Volume42.91K
Average Volume (3M)576.68K
Market Cap
$303.46M
Enterprise Value$409.25M
Total Cash (Recent Filing)$3.63M
Total Debt (Recent Filing)$2.59M
Price to Earnings (P/E)―
Beta1.29
Next Earnings
May 01, 2025EPS Estimate
-0.31Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.49
Shares Outstanding49,910,393
10 Day Avg. Volume600,926
30 Day Avg. Volume576,678
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.24
Price to Cash Flow (P/CF)-13.00
P/FCF Ratio0.00
Enterprise Value/Market Cap1.35
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit4.11
Enterprise Value/Ebitda-5.21
Forecast
1Y Price Target
$10.81Price Target Upside77.50% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering9
---
Bulls Say, Bears Say
Bulls Say
Financial PerformanceTotal revenue exceeded consensus estimates, indicating stronger-than-expected performance.
Revenue GrowthCommercial revenue increased by 37% year over year, and the number of commercial therapies increased from 14 to 19, showing signs of growth in the business.
Strategic PartnershipsThe strategic partnership with DHL allows CYRX to leverage DHL's global health logistics capabilities and presents an opportunity for CYRX to further expand its reach in global growth markets, particularly APAC and EMEA.
Bears Say
Healthcare Market RisksSignificant uncertainty remains in the healthcare market due to tariffs, China tensions, and turnover at FDA and NIH, which could drive downside risks.
Market UncertaintyBroader pharmaceutical uncertainty, along with NIH and FDA changes, keep the stock at an equal weight rating despite the recent pullback.
---
Ownership Overview
2.65% Insiders
18.54% Mutual Funds
36.53% Other Institutional Investors
24.45% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CYRX FAQ
What was CryoPort Inc’s price range in the past 12 months?
CryoPort Inc lowest stock price was $4.58 and its highest was $20.11 in the past 12 months.
What is CryoPort Inc’s market cap?
CryoPort Inc’s market cap is $303.46M.
When is CryoPort Inc’s upcoming earnings report date?
CryoPort Inc’s upcoming earnings report date is May 01, 2025 which is in 29 days.
How were CryoPort Inc’s earnings last quarter?
CryoPort Inc released its earnings results on Mar 04, 2025. The company reported -$0.42 earnings per share for the quarter, missing the consensus estimate of -$0.293 by -$0.127.
Is CryoPort Inc overvalued?
According to Wall Street analysts CryoPort Inc’s price is currently Undervalued.
Does CryoPort Inc pay dividends?
CryoPort Inc does not currently pay dividends.
What is CryoPort Inc’s EPS estimate?
CryoPort Inc’s EPS estimate is -0.31.
How many shares outstanding does CryoPort Inc have?
CryoPort Inc has 49,910,393 shares outstanding.
What happened to CryoPort Inc’s price movement after its last earnings report?
CryoPort Inc reported an EPS of -$0.42 in its last earnings report, missing expectations of -$0.293. Following the earnings report the stock price went up 30.632%.
Which hedge fund is a major shareholder of CryoPort Inc?
Currently, no hedge funds are holding shares in CYRX
---
CryoPort Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$10.81 (77.50% Upside)
$10.81 (77.50% Upside)
Blogger Sentiment
Bearish
CYRX Sentiment 100%
Sector Average 67%
Sector Average 67%
Hedge Fund Trend
Decreased
By 72.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $97.3K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.2%
Last 30 Days ▲ 9.1%
Last 30 Days ▲ 9.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-66.40%
12-Months-Change
Fundamentals
Return on Equity
-25.76%
Trailing 12-Months
Asset Growth
-26.55%
Trailing 12-Months
Company Description
CryoPort Inc
Cryoport, Inc., a life sciences services company, provides temperature-controlled logistics solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking and monitoring, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, which is used to ensure that the stability of shipped biologic commodities is maintained throughout the shipping cycle. It also provides information dashboards and validation documentation for shipments through data collected by the SmartPak Condition Monitoring System; and vacuum insulated aluminum dewars and cryogenic freezers systems. In addition, the company offers biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; transportation of frozen biological specimens to and from customer locations; and management of incoming and outgoing biological specimens, as well as provides logistics support and management; and short-term logistics and engineering consulting services. It serves biopharma/pharma, animal health, and human reproductive medicine markets. The company was founded in 1999 and is headquartered in Brentwood, Tennessee.
---
CYRX Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted strong revenue performance, particularly in the Life Sciences Services business and commercial revenue growth. The company achieved significant improvements in gross margin and is optimistic about future revenue growth and profitability in 2025. However, macroeconomic challenges and concerns over the China market were noted as lowlights.Read More>---
CYRX Stock 12 Month Forecast
Average Price Target
$10.81
▲(77.50% Upside)
Technical Analysis
Charles River Labs
―
Icon
―
Perrigo Company
―
Sarepta Therapeutics
―
BioLife Solutions
―
Best Analysts Covering CYRX
1 Year
1 Year Success Rate
8/13 ratings generated profit
1 Year Average Return
+39.52%
reiterated a buy rating 2 days ago
Copying Richard Baldry's trades and holding each position for 1 Year would result in 61.54% of your transactions generating a profit, with an average return of +39.52% per trade.
---